Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of IPN10200 for moderate to severe glabellar lines in Chinese adults
CTR20262240Phase 3Active
- Sponsor
- Ipsen
- Start
- Aug 2026
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of corabotase in glabellar furrowing, sponsored by Ipsen. Started Aug 2026; status: active.
02
Drugs
corabotase
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20262240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262240.